eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2022
vol. 26
 
Share:
Share:
abstract:
Case report

Hypofractionated radiotherapy for renal cell carcinoma with inferior vena cava tumour thrombus

Karolina Bełdzińska
1, 2
,
Konrad Gądek
3
,
Jacek Rutkowski
3

1.
Department of Hematology and Transplantology, University Clinical Centre in Gdansk, Gdansk, Poland
2.
Students Scientific Circle of the Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
3.
Department of Oncology and Radiotherapy, University Clinical Centre in Gdansk, Medical University of Gdansk, Poland
Contemp Oncol (Pozn) 2022; 26 (4): 310–313
Online publish date: 2023/01/30
View full text Get citation
 
PlumX metrics:
Renal cell carcinoma (RCC) constitutes about 3% of all malignant neoplasms in adults. Clear cell carcinoma is the most frequent type, accounting for about 65% of cases. It tends to invade the veins and form tumour thrombi in inferior vena cava (IVC-TT), occasionally reaching the right atrium. Nephrectomy and thrombectomy are standard therapeutic procedures performed in RCC-IVC-TT. Despite proven effectiveness of surgery, this entity in IVC-TT is associated with poor outcome. The role of palliative radiotherapy in this entity is undetermined. We present a case of a 43-year-old female patient after right-sided nephrectomy due to advanced RCC which invaded the IVC, hepatic veins, and right atrium. The patient has been treated with postoperative, hypofractionated radiotherapy on the residual disease.
keywords:

radiotherapy, renal cancer, case report, renal cell carcinoma, inferior vena cava thrombus, radiation oncology, hypofractionated radiotherapy, IVC-TT

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.